DaeJeon, South Korea

Mijeong Park

This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mijeong Park. Retrieved from https://idiyas.com/inventor/mijeong-park-vml4vri3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mijeong Park: Innovator in Brain Disease Treatment

Introduction

Mijeong Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment and prevention of brain diseases. His innovative work has the potential to impact many lives.

Latest Patents

Mijeong Park holds a patent for an ethyl acetate extract and compounds isolated therefrom. This invention is aimed at preventing and treating brain diseases such as Alzheimer's disease, stroke, and Parkinson's disease. It also addresses cell and tissue damage caused by ischemia and cardiovascular system diseases like myocardial infarction. This patent highlights his commitment to advancing medical treatments.

Career Highlights

Mijeong Park is affiliated with the Korea Institute of Science and Technology. His work at this prestigious institution has allowed him to focus on groundbreaking research that addresses critical health issues. His dedication to innovation in the medical field is evident through his patent and ongoing research efforts.

Collaborations

Mijeong Park collaborates with esteemed colleagues such as Hokoon Park and Yong Sup Lee. These partnerships enhance the research and development of effective treatments for brain diseases.

Conclusion

Mijeong Park is a pioneering inventor whose work in brain disease treatment showcases the importance of innovation in medicine. His contributions have the potential to change the landscape of healthcare for those affected by serious neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…